Page last updated: 2024-10-31

metyrapone and Diabetes Mellitus, Lipoatrophic

metyrapone has been researched along with Diabetes Mellitus, Lipoatrophic in 2 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Diabetes Mellitus, Lipoatrophic: A type of diabetes mellitus that is characterized by severe INSULIN RESISTANCE and LIPODYSTROPHY. The latter may be generalized, partial, acquired, or congenital (LIPODYSTROPHY, CONGENITAL GENERALIZED).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
RUVALCABA, RH2
SAMOLS, E1
KELLEY, VC2

Other Studies

2 other studies available for metyrapone and Diabetes Mellitus, Lipoatrophic

ArticleYear
LIPOATROPHIC DIABETES. I. STUDIES CONCERNING ENDOCRINE FUNCTION AND CARBOHYDRATE METABOLISM.
    American journal of diseases of children (1960), 1965, Volume: 109

    Topics: Adolescent; Carbohydrate Metabolism; Diabetes Mellitus, Lipoatrophic; Diabetes Mellitus, Type 1; Dru

1965
LIPOATROPHIC DIABETES. II. METABOLIC STUDIES CONCERNING THE MECHANISM OF LIPEMIA.
    American journal of diseases of children (1960), 1965, Volume: 109

    Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Cholesterol; Diabetes Mellitus, Lipoatrophic;

1965